Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Start-Up Applying Artificial Intelligence to New Drug Uses

A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs. . . . → Read More: Start-Up Applying Artificial Intelligence to New Drug Uses

Smartphone Data Reveal Physical Activity Worldwide

A data science team tapped into smartphones of more than 717,000 people worldwide to capture the number of steps they take each day as an indicator of physical activity. . . . → Read More: Smartphone Data Reveal Physical Activity Worldwide

Feasibility, Safety Shown for Personal Tumor Vaccine

A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor. . . . → Read More: Feasibility, Safety Shown for Personal Tumor Vaccine

Glaxo Using Artificial Intelligence for Drug Discovery

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Start-Up to Offer Neuro Disorder Speech Analytics App

A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders. . . . → Read More: Start-Up to Offer Neuro Disorder Speech Analytics App

Preclinical Data Show Promise for Diabetic Eye Drug

Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina. . . . → Read More: Preclinical Data Show Promise for Diabetic Eye Drug

Algorithm Quickly Customizes Walking Exoskeleton

Researchers at Carnegie Mellon University in Pittsburgh wrote and tested an algorithm for exoskeletons that customize the devices to a person’s walking pattern in about an hour. . . . → Read More: Algorithm Quickly Customizes Walking Exoskeleton

Computer-Designed Antibodies Target Alzheimer’s Proteins

Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease. . . . → Read More: Computer-Designed Antibodies Target Alzheimer’s Proteins

Institutions to Apply AI Models to Type 1 Diabetes

A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes. . . . → Read More: Institutions to Apply AI Models to Type 1 Diabetes

$10M Cancer Immunotherapy Research Fund Launched

A foundation is sponsoring research grants totaling $10 million for computational solutions to key questions facing cancer immunotherapy. . . . → Read More: $10M Cancer Immunotherapy Research Fund Launched